The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Laparoscopy compared with laparotomy for comprehensive surgical staging of early ovarian cancer: Results of a retrospective multicenter case-control study.
 
Julia Caroline Radosa
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; Gedeon Richter; Medac; Pfizer
 
Marc P Radosa
No Relationships to Disclose
 
Pauline Mertke
No Relationships to Disclose
 
Marie-Luise Hugo
No Relationships to Disclose
 
Christoph Georg Radosa
No Relationships to Disclose
 
Sara Brucker
Consulting or Advisory Role - MSD; Novartis; Olympus; Pfizer; Roche; Teva
Research Funding - Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD; Novartis; Olympus; Pfizer; Roche; Teva
 
Florin Andrei Taran
Consulting or Advisory Role - AstraZeneca; Genomic Health; Novartis; Roche; Tesaro; Teva
Travel, Accommodations, Expenses - Novartis; Tesaro
 
Stefan Kommoss
No Relationships to Disclose
 
Uwe Andreas Ulrich
No Relationships to Disclose
 
Andreas Hackethal
No Relationships to Disclose
 
Benjamin Tuschy
No Relationships to Disclose
 
Marc Suetterlin
No Relationships to Disclose
 
Martin Deeken
No Relationships to Disclose
 
Erich-Franz Solomayer
Honoraria - Erbe Elektromedizin; Storz
Research Funding - Saarland University Hospital
Other Relationship - Amgen; Arbeitsgemeinschaft Gynäkologische Endoskopie; AstraZeneca; Celgene; Gedeon Richter; Johnson & Johnson; Medac; MSD; Novartis; Pfizer; Roche; Takeda; Tesaro; Vifor Pharma